Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug 9;22(1):247.
doi: 10.1186/s12935-022-02670-3.

Exercise and colorectal cancer: prevention and molecular mechanisms

Affiliations
Review

Exercise and colorectal cancer: prevention and molecular mechanisms

Ramin Amirsasan et al. Cancer Cell Int. .

Abstract

Exercise and physical activity have been shown to be strongly associated with a decreased incidence rate of various chronic diseases especially numerous human malignancies. A huge number of clinical trials and meta-analysis have demonstrated that exercise is significantly effective in lowering the risk of colorectal cancer. In addition, it is suggested as an effective therapeutic modality against this cancer type. Therefore, in this review, we will review comprehensibly the effects of exercise in preventing, treating, and alleviating the adverse effects of conventional therapeutic options in colorectal cancer. Moreover, the possible mechanisms underlying the positive effects of exercise and physical activity in colorectal cancer, including regulation of inflammation, apoptosis, growth factor axis, immunity, epigenetic, etc. will be also discussed.

Keywords: Colorectal cancer; Exercise; Mechanisms; Physical activity; Prevention.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1
Fig. 1
molecular mechanisms underlying therapeutic effects of exercise in cancer
Fig. 2
Fig. 2
molecular mechanisms of preventive effects of exercise in colorectal cancer

Similar articles

Cited by

References

    1. Kasi A, Handa S, Bhatti S, Umar S, Bansal A, Sun W. Molecular pathogenesis and classification of colorectal carcinoma. Curr Colorectal Cancer Rep. 2020 doi: 10.1007/s11888-020-00458-z. - DOI - PMC - PubMed
    1. Safiri S, Sepanlou SG, Ikuta KS, Bisignano C, Salimzadeh H, Delavari A, et al. The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2019;4(12):913–933. doi: 10.1016/S2468-1253(19)30345-0. - DOI - PMC - PubMed
    1. Mustafa M, Menon J, Muniandy R, Illzam E, Shah M, Sharifa A. Colorectal cancer: pathogenesis, management and prevention. IOSR J Dent Med Sci. 2016;15:94–100. doi: 10.9790/0853-15100494101. - DOI
    1. Nourazarian SM, Nourazarian A, Majidinia M, Roshaniasl E. Effect of root extracts of medicinal herb Glycyrrhiza glabra on HSP90 gene expression and apoptosis in the HT-29 colon cancer cell line. Asian Pac J Cancer Prev. 2016;16(18):8563–8566. doi: 10.7314/APJCP.2015.16.18.8563. - DOI - PubMed
    1. Johnson CM, Wei C, Ensor JE, Smolenski DJ, Amos CI, Levin B, et al. Meta-analyses of colorectal cancer risk factors. Cancer Causes Control. 2013;24(6):1207–1222. doi: 10.1007/s10552-013-0201-5. - DOI - PMC - PubMed

LinkOut - more resources